10.1002/anie.201704133
Angewandte Chemie International Edition
COMMUNICATION
tBu
N
W. H. Chan, Chem. Rec. 2011, 11, 331; f) N. Jung, S. Bräse, Angew.
Chem. Int. Ed. 2012, 51, 5538; Angew. Chem. 2012, 124, 5632.
Review for 2-azirines, see: a) F. Palacios, A. M. O. Retana, E. M.
Marigorta, J. M. Santos, Eur. J. Org. Chem. 2001, 2401; b) A. F.
Khlebnikov, M. S. Novikov, Tetrahedron, 2013, 69, 3363. See also c) P.
B. Kryczka, A. Laurent, Tetrahedron Lett. 1977, 18, 31; d) R. B. Cheikh,
N. Bouzouita, H. G. R. Chaabouni, Tetrahedron 1990, 46, 5155.
E. Risberg, P. Somfai, Tetrahedron: Asymmetry, 2002, 13, 1957.
D. An, X. Guan, R. Guan, L. Jin, G. Zhang, S. Zhang, Chem. Commun.
2016, 52, 11211.
SO2Mes
N
SO2Mes
N
[7]
N
Et
S
O
Zn
N
H
O
P
OPh
OPh
Zn
Ph
N
Re-face
[8]
[9]
O
P
O
H
(PhO)2(O)P
Ph
N
[10] For kinetic resolution of 2H-azirines, see: a) H. Hu, Y. Liu, L. Lin, Y.
Zhang, X. Liu, X. Feng, Angew. Chem. Int. Ed. 2016, 55, 10098; Angew.
Chem. 2016, 128, 10252. For diastereoselective reaction of 2H-azirines
with nucleophiles; see: b) Y. S. P. Álvares, M. J. Alves, N. G. Azoia, J.
F. Bickley, T. L. Gilchrist, J. Chem. Soc. Perkin Trans. 1 2002, 1, 1911;
c) T. Sakai, Y. Liu, H. Ohta, T. Korenaga, T. Ema, J. Org. Chem. 2005,
70, 1369; d) F. Palacios, A. M. O. Retana, J. M. Alonso, J. Org. Chem.
2005, 70, 8895; e) T. Hirashita, S. Toumatsu, Y. Imagawa, S. Araki, J.
Setsune, Tetrahedron Lett. 2006, 47, 1613; f) F. Wang, N. Zhu, P.
Chen. J. Ye, G. Liu, Angew. Chem. Int. Ed. 2015, 54, 9356; Angew.
Chem. 2015, 127, 9488. For diastereoselective aza-Diels-Alder reaction
of 2H-azirins, see: g) Å. S. Timén, A. Fisher, P. Somfai, Chem.
Commun. 2003, 1150; h) Å. S. Timén, P. Somfai, J. Org. Chem. 2003,
68, 9958. For diastereoselective radical addition reaction to 2H-
azirines; see: i) E. Risberg, A. Fischer, P. Somfai, Chem. Commun.
2004, 2088; j) E. Risberg, A. Fischer, P. Somfai, Tetrahedron 2005, 61,
8443.
4a
Figure 5. Proposed transition state of the reaction of azirine 1a with 2 using
3h. H atoms have been omitted for clarity.
In conclusion, we developed a highly enantioselective reaction
of azirines with phosphite. The reaction was screened for a
broad range of azirines. This approach is the first example of a
highly enantioselective reaction of azirines with nucleophiles.
The obtained aziridines can be converted to chiral tetra-
substituted amines and oxazolines. We believe that the concept
described here will open doors to the asymmetric reaction of
azirines. Further studies are in progress to study the potential of
these catalytic systems for other processes and enantioselective
reaction of azirines.
[11] For reviews of the biological activity of α-amino phosphonic acids, see:
a) J. Hiratake, J. Oda, Biosci. Biotechnol. Biochem. 1997, 61, 211; b)
Aminophosphonic and Aminophosphinic Acids; Kukhar, V. P., Hudson,
H. R., Eds.; John Wiley & Sons: New York, 2000. For antibacterial
agent alafosfalin, see: c) J. G. Allen, F. R. Atherton, M. J. Hall, C. H.
Hassal, S. W. Holmes, R. W. Lambert, L. J. Nisbet, P. S. Ringrose,
Nature 1978, 272, 56. For anti-HIV agents, see: d) E. Alonso, A. Solis,
C. del Pozo, Synlett 2000, 698. For inhibitors of enzymes, see: e) R.
Hirschmann, A. B. Smith, III, C. M. Taylor, P. A. Benkovic, S. D. Taylor,
K. M. Yager, P. A. Sprengeler, S. J. Benkovic, Science 1994, 265, 234;
f) W. W. Smith, P. A. Bartlett, J. Am. Chem. Soc. 1998, 120, 4622.
[12] a) S. Nakamura, M. Hayashi, Y. Hiramatsu, N. Shibata, Y. Funahashi, T.
Toru, J. Am. Chem. Soc. 2009, 131, 18240. For recent studies on
enantioselective reaction with imines with phosphites from our group, b)
S. Nakamura, H. Nakashima, A. Yamamura, N. Shibata, T. Toru, Adv.
Synth. Catal. 2008, 350, 1209; c) M. Ohara, S. Nakamura, N. Shibata,
Acknowledgements
This work was supported by a Grant-in-Aid for Scientific Research
on Innovative Areas “Advanced Molecular Transformations by
Organocatalysts” from MEXT (26105727) and Uehara Memorial
Foundation.
Keywords: asymmetric synthesis · azirine · imidazoline ·
aziridine
[1]
a) D. Tanner, Angew. Chem. Int. Ed. 1994, 33, 599; Angew. Chem.
1994, 106, 625; b) W. McCoull, F. A. Davis, Synthesis 2000, 1347; c) X.
E. Hu, Tetrahedron 2004, 60, 2701; d) M. Pineschi, Eur. J. Org. Chem.
2006, 4979; e) C. Schneider, Angew. Chem. Int. Ed. 2009, 48, 2082;
Angew. Chem. 2009, 121, 2116.
Adv. Synth. Catal. 2011, 353, 3285.
For recent studies on
enantioselective reaction with ketimines from our group, see: d) N. Hara,
S. Nakamura, M. Sano, R. Tamura, Y. Funahashi, N. Shibata, Chem.
Eur. J. 2012, 18, 9276; e) M. Hayashi, M. Sano, Y. Funahashi, S.
Nakamura, Angew. Chem. Int. Ed. 2013, 52, 5557; Angew. Chem. 2013,
125, 5667; f) M. Hayashi, M. Iwanaga, N. Shiomi, D. Nakane, H.
Masuda, S. Nakamura, Angew. Chem. Int. Ed. 2014, 53, 8411; Angew.
Chem. 2014, 126, 8551; g) S. Nakamura, M. Sano, A. Toda, D. Nakane,
H. Masuda, Chem. Eur. J. 2015, 21, 3929; h) S. Nakamura, R. Yamaji,
M. Hayashi, Chem. Eur. J. 2015, 21, 9615; i) S. Nakamura, S.
Takahashi, Org. Lett. 2015, 17, 2590; j) S. Nakamura, N. Matsuda, M.
Ohara, Chem. Eur. J. 2016, 22, 9478; k) S. Nakamura, R. Yamaji, M.
Iwanaga, Chem. Commun. 2016, 52, 7462.
[2]
[3]
[4]
Reviews, see: a) F. M. D. Ismail, D. O. Levitsky, V. M. Dembitsky, Eur.
J. Med. Chem. 2009, 44, 3373; b) G. Singh, Mini Reviews in Medicinal
Chemistry, 2016, 16, 892.
a) T. Hata, T. Hoshi, K. Kanamori, A. Matsumae, Y. Sano, T. Shima, R.
Sugawara, J. Antibiot. 1956, 9, 141; b) Y. Q. Mao, M. Varoglu, D. H.
Sherman, Chem. Biol. 1999, 6, 251.
a) T. Tsuchida, H. Iinuma, N. Kinoshita, T. Ikeda, R. Sawa, Y.
Takahashi, H. Naganawa, T. Sawa, M. Hamada, T. Takeuchi. J.
Antibiot, 1993, 46, 1772; b) T. Tsuchida, H. Iinuma, N. Kinoshita, T.
Ikeda, T. Sawa, M. Hamada, T. Takeuchi, J. Antibiot. 1995, 48, 217; c)
T. Tsuchida, R. Sawa, Y. Takahashi, H. Iinuma, T. Sawa, H. Naganawa,
T. Takeuchi, J. Antibiot. 1995, 48, 1148.
[13] M. Hayashi, N. Shiomi, Y. Funahashi, S. Nakamura, J. Am. Chem. Soc.
2012, 134, 19366.
[5]
[6]
a) Y. Nakao, M. Fujita, K. Warabi, S. Matsunaga, N. Fusetani, J. Am.
Chem. Soc. 2000, 122, 10462; b) H. Konno, K. Kubo, H. Makabe, E.
Toshiro, N. Hinoda, K. Nosaka, K. Akaji, Tetrahedron 2007, 63, 9502.
For a review on enantioselective formation of aziridines, see: a) H. M. I.
Osborn, J. Sweeney, Tetrahedron: Asymmetry 1997, 8, 1693; b) P.
Müller, C. Fruit, Chem. Rev. 2003, 103, 2905; c) R. Chawla, A. K. Singh,
L. D. S. Yadav, RSC Adv. 2013, 3, 11385; d) H. Pellissier, Adv. Synth.
Catal. 2014, 356, 1899. See also: e) J. W. W. Chang, T. M. U. Ton, P.
[14] For chiral ligand having imidazoline and phenol, see; a) T. Arai, N.
Yokoyama, A. Yanagisawa, Chem. Eur. J. 2008, 14, 2052; b) T. Arai, N.
Yokoyama, Angew. Chem. Int. Ed. 2008, 47, 4989; Angew. Chem.
2008, 120, 5067; c) N. Yokoyama, T. Arai, Chem. Commun. 2009,
3285; d) T. Arai, N. Yokoyama, A. Mishiro, H. Sato, Angew. Chem. Int.
Ed. 2010, 49, 7895; Angew. Chem. 2010, 122, 8067; e) T. Arai, A.
Awata, M. Wasai, N. Yokoyama, H. Masu, J. Org. Chem. 2011, 76,
5450; f) A. Awata, T. Arai, Chem. Eur. J. 2012, 18, 8278; g) T. Arai, Y.
This article is protected by copyright. All rights reserved.